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Abstract
Background: Adults with chronic Trypanosoma cruzi exhibit a poorly functional T cell compartment, characterized by
monofunctional (IFN-c-only secreting) parasite-specific T cells and increased levels of terminally differentiated T cells. It is
possible that persistent infection and/or sustained exposure to parasites antigens may lead to a progressive loss of function
of the immune T cells.
Methodology/Principal Findings: To test this hypothesis, the quality and magnitude of T. cruzi-specific T cell responses
were evaluated in T. cruzi-infected children and compared with long-term T. cruzi-infected adults with no evidence of heart
failure. The phenotype of CD4+ T cells was also assessed in T. cruzi-infected children and uninfected controls. Simultaneous
secretion of IFN-c and IL-2 measured by ELISPOT assays in response to T. cruzi antigens was prevalent among T. cruzi-
infected children. Flow cytometric analysis of co-expression profiles of CD4+ T cells with the ability to produce IFN-c, TNF-a,
or to express the co-stimulatory molecule CD154 in response to T. cruzi showed polyfunctional T cell responses in most T.
cruzi-infected children. Monofunctional T cell responses and an absence of CD4+TNF-a+-secreting T cells were observed in T.
cruzi-infected adults. A relatively high degree of activation and differentiation of CD4+ T cells was evident in T. cruzi-infected
children.
Conclusions/Significance: Our observations are compatible with our initial hypothesis that persistent T. cruzi infection
promotes eventual exhaustion of immune system, which might contribute to disease progression in long-term infected
subjects.
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Introduction
Chagas disease, a neglected tropical disease affecting approx-
imately 10 million people from south of the United States to
Mexico and Central and South America [1], is caused by the
protozoan parasite Trypanosoma cruzi. As a consequence of
migration flows, the disease has been also become established in
non-endemic countries [2].
T. cruzi frequently results in the development of cardiomyop-
athy, generally many years after the initial infection. Three factors
are likely associated with the development of severe disease:
parasite burden; the effectiveness of the host immune response in
controlling parasites in specific tissues, and the effectiveness of the
host immune response in limiting peripheral damage [3,4].
Chronic infections in general are associated with a progressive
loss of pathogen-specific T cell function known as immune
exhaustion [5,6]. We have previously shown that adults with
chronic T. cruzi-infections exhibit a prevailing profile of parasite-
specific Interferon (IFN)-c only secreting T cells [7], associated
with long-term antigen persistence and exhausted T cells [5]. The
frequencies of T. cruzi-specific T cells were also found to inversely
correlate with the severity of chronic Chagas disease [7,8].
Although, T. cruzi-infected children are likely to have shorter-
term infections than most adults, the overall CD8 T cell
compartment in children in the early phase of chronic T. cruzi
infection exhibits decreased levels of naı¨ve T cells and increased
levels of terminally differentiated antigen-experienced T cells [9].
Other studies have suggested that T. cruzi-infected children have a
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mixed T cell profile with the production of IFN-c and IL-4
[10,11]. However, a comprehensive analysis of the ability of T.
cruzi specific T cells to co-express multiple functions has not been
performed.
In order to examine the progression of immune exhaustion in
chronic T. cruzi infection, we have assessed the quantitative and
qualitative attributes of T. cruzi-specific T cell responses in early
stages of Chagas disease in children in comparison to T. cruzi-
infected adults. The degree of activation, differentiation and
antigen exposure of total CD4+ T cells was also evaluated in T.
cruzi-infected children. The primary finding is that T. cruzi-infected
children have a higher frequency of polyfunctional and more
robust T cell responses specific for T. cruzi compared to T. cruzi-
infected adults, and a heightened state of immune activation of
CD4+ T cells.
Materials and Methods
Ethics statement
This protocol was approved by the Institutional Review Boards
of the Hospital Interzonal General de Agudos Eva Pero´n, and the
Centro Nacional de Gene´tica, Buenos Aires, Argentina. Informed
written consent was obtained from adult subjects and the parents
of all children included in this study.
Study subjects
Five to 16-year old children and 29 to 63 year-old adults were
enrolled at the Instituto Nacional de Parasitologı´a Dr. Mario
Fatala Chaben and at the Hospital Interzonal General de Agudos
Eva Pero´n, (Buenos Aires, Argentina). T. cruzi infection was
determined by indirect immunofluorescence, haemagglutination
and ELISA assays [12]. Subjects positive on at least two of these
tests were considered to be infected. All infected children were in
the early chronic phase of T. cruzi infection. Age- and sex-matched
children with negative serological findings were recruited as
uninfected controls. T. cruzi-infected subjects were classified
according to a modified version of the Kuschnir grading system
[13,14]. Most subjects were in the indeterminate phase of the
infection (Group 0; positive serology and normal findings on
electrocardiogaphy, chest radiography and echocardiography),
while 3 subjects (2 adults and one child) belong to the Group 1
group (positive serology, abnormal findings on electrocardiogra-
phy and normal chest radiography and echocardiography). All
participants of this study had not received etiological treatment at
the time of sampling and started drug therapy with benznidazole
after sampling.
Children and adults with any impaired health condition such as
severe nephropathy, liver disease, severe neuropathy, severe
anaemia or homeopathy were excluded from the study. Data on
the number, sex, age, clinical and epidemiologic features of the
subjects included in this study are summarized in Table 1.
Collection of peripheral blood mononuclear cells (PBMC)
and sera
Approximately 10 mL of blood were drawn by venipuncture
into heparinized tubes (Vacutainer; BD Biosciences). PBMC were
isolated by density gradient centrifugation on Ficoll-Hypaque
(Amersham) and were cryopreserved for later analysis. Additional
2 mL of blood were allowed to coagulate at 37uC and centrifuged
at 1000 g for 15 min for sera separation.
Antigens
Protein lysate from T. cruzi amastigotes was obtained by freeze/
thaw cycles followed by sonication as previously reported
[8].Tetanol Pur (Novartis, Germany) was used as source of tetanus
toxoid.
HLA-A01, A02, A03, A24 and B44-supertype binding epitopes
encoded by the trans-sialidase gene family of T. cruzi and peptides
derived from Influenza (Flu) virus with high binding-affinity for the
common class I HLA-supertypes A01, A02 and A03 were
synthesized at the University of Georgia Molecular Genetics
Instrumentation Facility (Athens, USA).
IFN-c and IL-2 enzyme-linked immunosorbent spot
(ELISPOT) assays
The number of T. cruzi antigen-responsive IFN-c- and IL-2-
secreting T cells was determined by ex vivo ELISPOT using
commercial kits (BD Biosciences), as described elsewhere [7,8,15].
Cryopreserved PBMC were seeded in triplicate wells, at a
concentration of 46105 cells/well, and stimulated with T. cruzi
lysate (10 mg/mL) or with peptide pools from the trans-sialidase
protein family (7–13 peptides per pool, 5 mg/ml/peptide). For
controls, PBMCs were incubated with either 20 ng/mL phorbol
12-myristate 13-acetate (PMA, Sigma) plus 500 ng/mL ionomycin
(Sigma), Flu virus (3 peptides per pool, 5 mg/ml/peptide), tetanus
toxoid (4 I.U./ml) or media alone (unstimulated control) for 16–
20 hr at 37uC and 5% CO2. Spot forming cells (SFC) were
automatically enumerated using ImmunoSpot analyzer (CTL).
The mean number of spots in triplicate wells was obtained for each
condition, and the number of specific IFN-c and IL-2-secreting T
cells was calculated by subtracting the value of the wells containing
media alone from the antigen-stimulated spot count. Responses
were considered significant if a minimum of 10 spots/46105
PBMC were present per well, and additionally, this number was at
least twice the value of wells with media alone [8].
Whole blood intracellular and surface staining assays
For polyfunctional analysis, 200 mL heparinized blood, half
diluted in RPMI, were incubated with T. cruzi lysate in the
presence of anti-CD28 and anti-CD49d antibodies (1 mg/ml; BD
Pharmingen), for 16–20 h at 37uC. Ten mg/ml brefeldin A (Sigma)
Author Summary
Chagas disease is a neglected tropical disease affecting
approximately 10 million people in the world. As a
consequence of migration flows, the disease has also
become established in non-endemic countries. Previous
studies have demonstrated that Trypanosoma cruzi-specif-
ic T cells inversely correlates with the severity of cardiac
disease in the chronic phase of the infection, suggesting
that the immune system becomes exhausted overtime. To
test this hypothesis, the quality and magnitude of T. cruzi-
specific T cell responses were measured in T. cruzi-infected
children – who are presumed to have shorter-term
infections - and compared with long-term T. cruzi-infected
adults. The activation status of total T cells in T. cruzi-
infected children was also evaluated. T. cruzi-infected
children exhibit a more robust, and more highly functional
parasite specific T cell responses compared to T. cruzi-
infected adults. In spite of a more functional immune
profile, T. cruzi-infected children have a heightened state
of immune activation. These observations are compatible
with the initial hypothesis that T cell responses specific for
T. cruzi become exhausted overtime. The impairment in T
cell responses might contribute to disease progression in
long-term infected subjects.
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were added for the last 5 h of incubation, as previously described
[16]. Blood incubated with no antigen served as a negative control
(unstimulated control), while blood incubated with Staphylococcal
enterotoxin B (1 mg/ml; Sigma-Aldrich) served as a positive
control. Twenty mM EDTA was added for 15 min. Cells were
then stained with anti-human CD4-peridinin chlorophyll protein
(PerCP) ensued by red cell lysis and white cell fixation in FACS
Lysing Solution (Pharmingen). This was followed by fixation and
permeabilization with Cytofix/Cytoperm solution (Pharmingen)
according to manufacturer’s instructions. Cells were stained with a
combination of monoclonal antibodies specific for IFN-c [phyco-
erythrin (PE)], tumor necrosis factor (TNF)-a [allophycocyanin
(APC)] and CD154 (CD40L) [fluorescein isothiocyanate (FITC)],
all from BD Bioscience. Since CD154 is only transiently expressed
on the cell surface [17], intracellular expression of CD154 was
measured, as previously described [18]. In order to confirm that
cytokine/co-stimulation expression was derived from T cells, anti-
human CD3-FITC or CD3-PerCP was added in polyfunctional
staining assays in combination with CD4, IFN-c and TNF-a or
CD4, IFN-c and CD154, respectively.
Typically, 500,000 lymphocytes were acquired on a FACSca-
libur (Becton Dickinson Immunocytometry Systems) and analyzed
using FlowJo software (TreeStar, Inc.) Lymphocytes were identi-
fied based on their scatter patterns and CD4 expression for the
combination of IFN-c, TNF-a and CD154; and based on scatter
patterns as well as CD3 and CD4 expression for the combination
of IFN-c and TNF-a or IFN-c and CD154. Boolean combination
gating was then performed to calculate the frequencies of
expression profiles corresponding to the seven different combina-
tions of functions by using the FlowJo software. After subtracting
the background values, the proportions of the different subsets
were expressed as percentages of total cytokine or CD154-positive
cells. Responses to the T. cruzi lysate were considered positive, for
any particular subset, if the frequency of cytokine/CD154-positive
T cells was threefold higher than the frequency in medium alone
and above 0.07% of total CD4+ T cells, since the limit of detection
was set at 0.01%.
Whole blood surface staining assays
For phenotypic analysis of total CD4+ T cells, 50 mL of whole
blood were incubated with different combinations of CD4
(PerCP), CD45RA (FITC or APC), CD27 (PE), CD28 (PE),
CD127 (PE), HLA-DR (FITC) and KLRG1 (APC) monoclonal
antibodies (BD Biosciences), followed by red cell lysis and white
cell fixation in FACS Lysing Solution (Pharmingen). Typically,
500,000 lymphocytes were acquired on the FACScalibur (Becton
Dickinson Immunocytometry Systems) and analyzed using FlowJo
software (TreeStar, Inc.)
Statistical analysis
Demographic and clinical characteristics of T. cruzi-infected
subjects included in this study were summarized using range and
median and compared with healthy participants using Kruskal-
Wallis test with Dunn correction and Fisher’s exact tests for
numerical and categorical variables, respectively. Comparisons of
the frequencies of responders in the different categories of
ELISPOT responses among T. cruzi-infected children and between
T. cruzi-infected children and the uninfected group were evaluated
by use of the chi 2 test and Fisher’s exact test. To compare the
number of spots,as well as the magnitude of CD4+ T cells
responses among triple, double or single functional profiles, the
Kruskal-Wallis nonparametric analysis with Dunn correction was
used. The percentages of responding CD4+ T cells for each
cytokine within and among the children and adult groups were
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compared by the Kruskal-Wallis nonparametric analysis with
Dunn correction and Mann-Whitney U test, respectively. T cell
phenotypes in T. cruzi-infected children and uninfected controls
were compared applying the Mann-Whitney U-test. Differences
were considered to be statistically significant at P,0.05.
Results
Clinical and demographic characteristics of study
population
The main characteristics of the entire study population are
summarized in Table 1. T. cruzi-infected and uninfected children
enrolled in the study were all born from mothers with positive
serology for T. cruzi infection and, at the time of the study all
children were living in Buenos Aires, where T. cruzi infection is not
endemic. T. cruzi-infected and uninfected groups of children
included individuals born in areas endemic for T. cruzi infection
and individuals born in non-endemic areas. Seropositive children
who had not lived in endemic areas are presumed to have been
infected congenitally. Only one child out of the fifty T. cruzi-
infected children showed a right bundle branch block that is
among the electrocardiographic alterations related to Chagas
disease. Abnormal findings in the electrocardiography not related
to Chagas disease, including sinusal tachycardia, incomplete right
bundle branch block and premature atrial contraction [19], were
more frequent among T. cruzi-infected children born in areas
endemic for T. cruzi infection than those born in non-endemic
areas (Table 1). The presence of these electrocardiographic
alterations were not correlated with the age or gender of children.
All T. cruzi-infected adults were born in areas endemic for T. cruzi
infection but have lived in Buenos Aires for more than 15 years, in
average. Two adult patients belonged to the G1 clinical stage of
the Kuschnir classification [13], showing left anterior fascicular
block while the remaining 8 subjects belong to the G0 group.
Frequencies of cytokine-producing cells specific for T.
cruzi in children in early stages of Chagas disease
We have previously reported an inverse correlation between the
frequency of IFN-c-producing T cells responsive to T. cruzi
antigens and disease severity in chronically infected adults [7,8]. In
this study, the magnitude of T. cruzi-specific T cell responses was
assessed in 17 T. cruzi-infected children by measuring the total
frequency of IFN-c- and IL-2-producing cells by ELISPOT assays
after stimulation of PBMC with T. cruzi antigens. Since we had
shown that in chronically T. cruzi-infected humans, the frequency
of T cells specific for class-I-restricted T. cruzi epitopes (CD8+
epitopes) [7,8] or T. cruzi–derived recombinant proteins [20] is low
to be consistently detected, an amastigote lysate preparation was
the primary antigen stimulus for ELISPOT assays.
More than 75% of infected children had detectable cytokine
responses to T. cruzi-antigens, with secretion of IFN-c and IL-2 in
nearly 60% of T. cruzi-infected children and, approximately 18%
with IFN-c-only responses. IL-2-only responses were not observed
in T. cruzi-infected children (Table 2). None of the seronegative
children born from mothers with positive serology for T. cruzi
infection had positive ELISPOT responses (Table 2). The number
of IFN-c spots in subjects with concomitant IFN-c and IL-2
positive ELISPOT responses was higher than the number of IFN-
c spots in IFN-c-only responders (Figure 1A). Likewise, the former
group showed higher spot counts for IFN-c than IL-2
PBMC available from five T. cruzi-infected children were also
stimulated with peptides encoded by the trans-sialidase gene family
that bind alleles representative of the 6 most common class I HLA-
supertypes, previously shown as targets of CD8+ T cell responses
in chronically T. cruzi-infected adults [7]. Strong IFN-c ELISPOT
responses specific for five out of the six supertype-binding trans-
sialidase pooled peptides assessed were observed in one out of the
five children (Figure 1B). In this same child, strong IL-2 responses
to HLA-A3 and HLA-A24-binding peptides were also detected
(Figure 1B). In opposition to T. cruzi-specific T cell responses, the
magnitude of IFN-c ELISPOT responses to irrelevant antigens,
including class-I-restricted Flu peptides and tetanus toxoid, did not
differ among uninfected children, uninfected adults and T. cruzi-
infected adults (Figure 2), supporting the impairment of T cell
responses is restricted to T. cruzi.
Cytokine/costimulation coexpression profiles in T. cruzi-
infected children and adults
To further determine the quality of T. cruzi specific T cell
responses earlier in infection, cytokine/co-stimulation co-expres-
sion profiles were assessed by intracellular staining following
stimulation of whole blood with T. cruzi lysate. Since the T. cruzi
lysate has proved to mainly induce CD4+ T cell responses and to a
much lesser extent CD8+ T cell responses in chronic T. cruzi-
infections [7,8], we focused on CD4+ T cell responses for flow
cytometry assays. The ability of CD4+ T cells to produce IFN-c,
TNF-a and CD154 (CD40L) - a marker of costimulatory potential
- was evaluated in 19 T. cruzi-infected children. For comparison,
this functional profile was also assessed in 10 T. cruzi-infected
adults without evidence of cardiac involvement or with mild
cardiac disease. Examining IFN-c, TNF-a and CD154+ individ-
ually, CD154 was the most highly expressed in T. cruzi-infected
children and there was a trend for higher proportions of cells
expressing one or more of these three markers in the in the T.
Table 2. Trypanosoma cruzi-specific T cell responses in children with Chagas disease and uninfected subjects living in non-
endemic areas of Argentina, measured by IFN-c and IL-2 ELISPOT.
No. of positive responders/total no. of subjects evaluated (%)
Positive ELISPOT responses to T. cruzi lysate T. cruzi-infected Uninfected
IFN-c+IL-2 10/17 (58.8)A, B, C 0/15 (0)
IFN-c-only 3/17 (17.6)D 0/15 (0)
IL-2-only 0/17 0/15
AFisher exact test p = 0.0181 vs. percentage of IFN-c-only responders in T. cruzi-infected subjects.
BFisher exact test p = 0.0003 vs. percentage of IL-2-only responders in T. cruzi-infected subjects.
CFisher exact test p = 0.0003 vs. percentage of IFN-c+IL-2 responders in the uninfected group.
DFisher exact test p = 0.23 vs. percentage of responders in the uninfected group.
doi:10.1371/journal.pntd.0002575.t002
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cruzi-infected children relative to the adults (Figure 3 and Figure
S1). IFN-c-producing CD4+ T cells was prevalent among T. cruzi-
infected adults (Figure 3).
A Boolean gating analysis was then performed to categorize
cytokine/CD154 positive cells into seven different subsets consist-
ing of triple, double or single cytokine/CD154-expressing
populations. T. cruzi antigen responsive CD4+ T cells in children
with positive serology for T. cruzi infection had representatives of
all seven possible subsets (range 1–5 subsets per subject) (Figure 4A
and 4C). CD4+ T cells responding to the lysate exert at least 2
functions in .90% of T. cruzi-infected children (Figure 4D).
Polyfunctional cytokine-producing cells that simultaneously secrete
IFN-c and TNF-a dominated the CD4+ T cell responses in T.
cruzi-infected children, followed by monofunctional and double
expressing IFN-c+CD154+ CD4+ T cells. TNF-a+CD154+ and
triple expressing IFN-c+TNF-a+CD154+ cells represented, in
average, less than 20% of the total CD4+ T cell response to T.
cruzi-antigens (Figure 4A and 4C). In contrast to children, CD4+ T
cell responses in infected adults had representatives of only 3 out of
the 7 possible subsets (Figure 4B and 4C), with a higher proportion
of subjects displaying CD4+ T cells with single function than
double function and none with all three functions (Figure 4D). In
adult patients, monofunctional responses were dominated by IFN-
c-producing T cells followed by CD154+ T cells, whereas IFN-
c+CD154+ cells were predominant among the subsets with double
function (Figure 4B).
Monofunctional CD154+ followed by monofunctional IFN+ T
cells and double expressing IFN-c+CD154+ T cells showed the
highest magnitude of CD4+ T cell responses to T. cruzi antigens in
T. cruzi-infected children (Figure S2A). Likewise, monofunctional
T cells are also the main contributors to the total magnitude of
CD4+ T cell responses to the lysate in T. cruzi-infected adults, but
Figure 1. IFN-c and IL-2-secreting cells in response to
Trypanosoma cruzi antigens in T. cruzi-infected children. PBMC
from T. cruzi-infected children were seeded at 46105 cells/well and
stimulated with a T. cruzi lysate from the Brazil strain, class-I-restricted
HLA-A01, HLA-A02, HLA-A03, HLA-A24, HLA-B07 and HLA-B44 super-
type trans-sialidase peptide pools, class-I-restricted Flu-derived peptides
or media alone for 16–20 h. (A) T cell responses to a T. cruzi lysate
preparation. Each circle represents the mean spot number of triplicate
wells for each patient with positive ELISPOT responses out of seventeen
assessed. Spot counts with media alone were subtracted. Vertical lines
depicting median values are shown. IFN-c-DP, no. of IFN-c spots in
individuals with positive responses for both IFN-c and IL-2 ELISPOT
assays; IFN-c-SP, no. of IFN-c spots in individuals with positive ELISPOT
responses for IFN-c alone; IL-2-DP, no. of IL-2 spots in individuals with
positive responses for both IFN-c and IL-2 ELISPOT assays; IL-2-SP, no. of
IL-2 spots in individuals with positive ELISPOT responses for IL-2 alone.
(*) P,0.01 vs. IL-2-DP; vs. IL-2-SP and vs. IFN-c-SP by the Kruskal-Wallis
test with Dunn correction. (B) Class I-restricted IFN- c and IL-2 ELISPOT
responses to trans-sialidase peptides. Representative positive ELISPOT
responses for IFN-c (grey bars) and IL-2 (white bars) in a single subject
are shown. (*) Indicates positive responses, as defined in the Materials
and Methods.
doi:10.1371/journal.pntd.0002575.g001
Figure 2. IFN-c-secreting cells in response to Flu- and tetanus
toxoid-derived antigens in uninfected children, uninfected adults
and adults with chronic T. cruzi-infection. PBMC from uninfected
children (n = 6), uninfected adults (n = 7) and long-term T.cruzi-infected
adults (n = 10) were seeded at 46105 cells/well and stimulated with
class-I-restricted Flu-derived peptides (A), tetanus toxoid (B) or media
alone for 16–20 h. Each symbol represents the mean spot number of
triplicate wells for each patient with positive ELISPOT responses, as
defined in material and methods. Spot counts with media alone were
subtracted. Vertical lines depicting median values are shown. No
significant differences were found among groups.
doi:10.1371/journal.pntd.0002575.g002
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contrasting with children, T cell responses were enriched in single
IFN-c+ rather than single CD154+ T cells (Figure S2B).
CD4+ T cell phenotype in T. cruzi-infected children
We have previously reported that T. cruzi-infected children
exhibit increased levels of terminally differentiated CD8+ T cells in
the overall T cell compartment [9]. In this study, the phenotype of
total CD4+ T cells was evaluated for the expression of CD45RA,
the co-stimulation molecules CD27 and CD28, the lymph node
homing receptors CCR7 and CD62L, the IL-7 receptor CD127
and the co-inhibitory receptor killer-cell lectin like receptor G1
(KLRG-1), a marker of the number of TCR-triggering events
[21,22]. Highly differentiated memory T cells (CD45RA2CD272
CD282 and CD45RA2CCR72CD62L2) and terminally differ-
entiated effector T cells (CD45RA+CCR2CD62L2) are increased
in T. cruzi-infected children compared with uninfected controls
(Table 3). The increased expression of HLA-DR indicates a high
degree of activation of CD4+ T cells, while the increased
expression of KLRG-1 along with a loss of the IL-7 receptor,
suggests sustained antigen exposure of T cells in T. cruzi-infected
children.
Discussion
T cell deficiencies resulting from exhaustion include a hierarchi-
cal loss of effector functions along with the expression of inhibitory
receptors, and failure to exhibit antigen-independent homeostatic
proliferation [5,23,24]. Although, this phenomenon was initially
described for chronic viral infections, recent studies have shown that
this process can also occur in protozoan diseases [6,25]. We have
previously provided several pieces of evidence of immune exhaus-
tion in adults with chronic T. cruzi-infection [8,26–29].
In this study, we report for the first time that T. cruzi-infected
children in early stages of T. cruzi infection maintained polyfunctional
CD4+ T cells responsive to T. cruzi antigens in their circulation.
More than ninety percent of T. cruzi-infected children displayed
responsive CD4+ T cells with double or triple functions. These
findings are in sharp contrast to the profile observed in a group of
adults with chronic T. cruzi-infections, in which most subjects
showedmonofunctional T. cruzi-specific responses enriched in single
IFN-c+ T cells with absence of TNF-a+-producing T cells. Other
authors had also reported that children in the early phase of chronic
T. cruzi infection exhibit IFN-c+- and TNF-a+-secreting CD4+ T
cells in response to T. cruzi antigens [10,11].
The analysis of IFN-c ELISPOT responses to the lysate and to
trans-sialidase-derived class I peptides in T. cruzi-infected children
also revealed that not only were the proportion with polyfunctional
responses higher relative to infected adults, but that the magnitude
of IFN-c responses in these positive children was higher by 5-fold
than previously reported in chronically T. cruzi-infected adults (i.e.
median number of IFN-c spots/46105 PBMC in children = 220
vs. 52 spots evaluated in 150 subjects in the G0 group), [Laucella,
unpublished data, 7,8]. Of note, the one single child responsive to
trans-sialidase-derived CD8+ target peptides showed a stronger and
broader response compared with our previous findings in adults
(i.e. median number of IFN-c spots/46105 in this child = 87 spots,
with five out of the six supertype-binding trans-sialidase pooled
peptides recognized in average vs. 19 spots in 25 T. cruzi-infected
adults, with two out of six pooled peptides recognized in average)
[7]. The differences are even more dramatic when comparing T.
cruzi-infected children with adults exhibiting severe cardiomyop-
athy who mostly showed negative T cell responses against T. cruzi
antigens [7,8]. Recent studies have also shown that individuals
with severe cutaneous leishmaniasis have reduced CD8+ T cell
numbers with the ability to produce IFN-c and IL-2 [30].
Multifunctional T cells are optimized for effector function,
exhibiting a higher secretion of IFN-c on a per-cell basis, more
efficient killing, and IL-2-mediated expansion of T cells in an
autocrine or paracrine manner [31]. In agreement with these
findings, we observed a higher level of IFN-c production in T.
cruzi-infected children displaying both IFN+ and IL-2+ ELISPOT
responses compared with those with single IFN-c-producing T
cells. It is likely that the maintenance of polyfunctional T cell
responses provides more efficient control of T. cruzi infection and
limits peripheral tissue damage. Indeed, most T. cruzi-infected
children have not developed cardiac disease and previous studies
from our group have shown higher frequencies of IFN-c-
producing T cells and higher magnitude of these responses in
subjects with less severe forms of the disease compared with
patients with severe cardiomypathy [7,8,29]. Of note, seropositive
children who were born and lived for some years in areas endemic
for T. cruzi infection showed higher electrocardiographic abnor-
malities not related to Chagas disease compared to children born
in non-endemic areas. This is likely due to co-morbidities and
poorer socioeconomic conditions in rural areas. In this respect, we
have shown that socioeconomic conditions had a significant
influence on the progression of chronic Chagas disease which was
independent of antiparasitic treatment and clinic characteristics
[32]. Nevertheless, the magnitude and quality of T. cruzi-specific T
cell responses were not different between seropositive children
born in endemic areas and those born in non-endemic areas, who
are presumed to have been infected congenitally.
In T. cruzi infection, parasite persistence for decades, might
drive a process of immune exhaustion. A broader range (relative to
adults) of T. cruzi-specific immune phenotypes are present in T.
cruzi-infected children – from ‘‘adult-like’’ monofunctional CD4+
T cell subsets to T cells exhibiting up to 3 functional properties.
Thus, some T. cruzi-infected children display a T cell profile
similar to that of adult patients. This is not unexpected since some
Figure 3. Magnitude of CD4+ T cell responses in T. cruzi-infected
children and adults.Whole blood was stimulated with an amastigote
lysate preparation, and antigen-responsive CD4+ T cells were measured
using an intracellular staining assay for IFN-c, TNF-a and CD154. The
percentage of total responsive CD4+ T cells for each individual function
in nineteen T. cruzi-infected children (hatched columns) and ten adults
with chronic T. cruzi infection (black columns) is plotted. Boxes and
whiskers depicting median and 10th and 90th percentile values are
shown. (*) P = 0.03 vs. CD4+TNF-a+ in T. cruzi-infected children and (&)
P = 0.03 vs. CD4+TNF-a+ T cells in T. cruzi-infected adults by Kruskal-
Wallis test with Dunn correction; (**) P = 0.004 vs. CD4+CD154+ in T.
cruzi-infected adults and (<) P = 0.006 vs. CD4+TNF-a+ T cells in T. cruzi-
infected adults by Mann-Whitney U test.
doi:10.1371/journal.pntd.0002575.g003
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children will likely have infections of .10 years. The increased
frequencies of total effector/effector memory and activated CD4+
T cells in T. cruzi-infected children observed herein suggest a
heightened state of immune activation as previously suggested in
other studies [9,33,34] In contrast to the unaltered levels of naı¨ve
CD4+ T cells shown herein, previous studies by our group in a
similar patient population of children demonstrated a significant
decrease in the levels of naı¨ve CD8+ T cells compared to
uninfected children [9]. Likewise, Vitelli-Avelar reported de-
creased levels of CD62L+CD4+ T cells but lower frequencies of
CD4+HLA-DR+ T cells along with unaltered levels of
CD4+CD28+ T cells [35] in children in the indeterminate phase
of the infection. Adults with chronic T. cruzi infection also show
increased levels of activated, late differentiated memory and
effector T cells, while naı¨ve T cells are diminished as disease
becomes more severe [26,27,29,36]. A crucial question remains
whether the heterogeneity in the functional and phenotypic profile
is a predictor of different disease outcome in these patients.
Children have not only shorter term infections but are also
younger. Aging of the immune system in elderly subjects (generally
older than 65 years of age), known as immunosenescence [37], is
mainly associated to poor responsiveness to new pathogens and
reduced efficacy of vaccination-induced protection against infection,
while established memory immune responses to previously encoun-
tered pathogens are much less affected unless it is additionally
stressed by chronic infections or autoimmune diseases [38,39].
Several studies have shown accelerated immune aging in HIV-
infected subjects and subjects chronically infected with cytomega-
lovirus [40]. In this study, chronically
T. cruzi-infected subjects are younger than 60 years, in average,
and there were not differences in the magnitude of IFN-c
ELISPOT to irrelevant antigens like toxoid tetanus and Flu among
uninfected children, uninfected adults T. cruzi-infected adults,. Of
note, in previous studies, we did not found any association between
the magnitude of T cell responses specific for T. cruzi and age in a
cohort of chronically T. cruzi-infected subjects in an age range of
between 22 and 70 years [7,8]. Furthermore, CD4+ T cells
responsive to T. cruzi-antigens in T. cruzi-infected adults display
high expression of the inhibitory receptor CTLA-4 which is a
feature of exhausted T cells [41], while few T cells responsive to
tetanus and diphtheria toxoids expressed CTLA-4 [29], support-
ing that impairment in T cell responses in T. cruzi-infected adults
was confined to those specific for T. cruzi. The phenotype of the
overall T cell compartment with an expansion of end-differenti-
ated effector T cells and loss of naı¨ve T cells in T. cruzi-infected
children and adults compared with age-matched controls suggest
that chronic T. cruzi infection might accelerate immune aging
along with the induction of T cell exhaustion.
The quality of the immune response might also be a factor in
the higher cure rates following drug treatment observed in
Figure 4. Cytokine/costimulation profile of T. cruzi-specific CD4+ T cells in short-term and long-term T. cruzi infections. PBMC were
stimulated with a T. cruzi lysate preparation and cytokine/costimulation coexpression profiles with triple (ITD), double (IT, ID, TD) or single (I, T, D)
function were determined in nineteen T. cruzi-infected children (A) and ten adults with chronic T. cruzi infection (B) using the Boolean gating function
of FlowJo software. The proportions of CD4+ subsets positive for specific cytokines or co-stimulatory molecules were expressed as percentages of
total cytokine/costimulatory-positive CD4+ T cells. Mean and SD are shown. (C) Summary of the functional composition of the CD4+ T cell response.
Each slice of the pie represents the fraction of the total response that consists of CD4+ T cells positive for the different seven subsets. D) Prevalence of
polyfunctional CD4+ T cell responses in T. cruzi-infected children (left panel) and adults (right panel). Each slice of the pie represents the percent of
subjects with one (1+), two (2+) or three (3+) functions. I, IFN-c; T, TNF-a; D, CD154. ITD, proportion of CD4+ T cells with concomitant expression of
IFN-c, TNF-a and CD154; IT, proportion of CD4+ T cells with concomitant expression of IFN-c and TNF-a; ID, proportion of CD4+ T cells with
concomitant expression of IFN-c and CD154; TD, proportion of CD4+ T cells with concomitant expression of TNF-a and CD154; I, proportion of CD4+ T
cells with IFN-c only production; T, proportion of CD4+ T cells with TNF-a only production; D, proportion of CD4+ T cells with CD154 only expression.
doi:10.1371/journal.pntd.0002575.g004
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children relative to adults [42]. It had been proposed that IFN-c
production might promote the effectiveness of chemotherapy in
patients with chronic T. cruzi infections [12,43]. All the children
included in this study were treated with benznidazole, and are
currently under follow-up. It will be of interest to address whether
the response to therapy is associated with the qualitative and
quantitative characteristics of the anti-T.cruzi T cell response prior
to treatment.
Supporting Information
Figure S1 T. cruzi –specific CD4+ T cell profile in
children and adults with Chagas disease. Co-expression
profiles of CD4+ T cells with the ability to produce IFN-c, TNF-a,
or to express the co-stimulatory molecule CD154 were measured
by flow cytometry after 16–20 hs stimulation of whole blood with
a T. cruzi lysate preparation. (A) Representative dot plots from one
T. cruzi-infected child and one adult with chronic T. cruzi infection
are shown. The numbers in the upper right quadrant indicate the
percentage of CD4+IFN-c+, CD4+TNF-a+ or CD4+ CD154+ T
lymphocytes responsive to the lysate. (B) Representative dot blot of
IFN-c and TNF-a co-production by CD4+ T cells from the same
patients showed in A. The numbers in the upper right quadrant
indicate the percentage of CD4+IFN-c+TNF-a+ T cells, while the
numbers in the upper left represent the percentage of CD4+IFN-
c+TNF-a2 T lymphocytes on total CD4+ T cells.
(TIF)
Figure S2 T. cruzi-specific CD4+ T cell responses in
children and adults with Chagas disease. PBMC were
stimulated with a T. cruzi lysate preparation and stained for IFN-c,
TNF-a and CD154. Triple, double or single functional profiles
were determined by FlowJo Boolean gating analysis in nineteen T.
cruzi-infected children (A) and ten T. cruzi-infected adults (B). Data
are presented as the percentage of responding CD4+ T cells in
each subset. Boxes depicting median and 5th and 95th percentile
values are shown. I, IFN-c; T, TNF-a; D, CD154. (**) P,0.01 vs.
ITD and TD among T. cruzi-infected children; (&) P,0.05 vs. IT
and T among T. cruzi-infected children; (*) P,0.05 vs. ITD, IT,
TD and T among T. cruzi-infected adults, by the Kruskal-Wallis
test with Dunn correction.
(TIF)
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